Robert Weinberg receives 2021 Japan Prize
The award recognizes Weinberg’s pioneering achievements in the field of cancer biology.
Kerry Emanuel, David Sabatini, and Peter Shor receive BBVA Frontiers of Knowledge awards
Laureates recognized for contributions to climate change, biomedicine, and quantum cryptography.
Gift will allow MIT researchers to use artificial intelligence in a biomedical device
Device developed within the Department of Civil and Environmental Engineering has the potential to replace damaged organs with lab-grown ones.
MIT’s research enterprise in Singapore launches new group, boosting cell therapy research
SMART's new Critical Analytics for Manufacturing Personalized-Medicine (CAMP) group aims to overcome challenges in life-changing cell therapies.
Fine-tuning cancer medicine
New cancer research initiative eyes individualized treatment for patients.
MIT NEWDIGS hosts design lab on new gene and oncology therapy financing models
Industry leaders, patient advocates, and policymakers collaborate to lower barriers to potentially curative treatments.
Francis Collins: Scientists must engage with the world
In Compton Lecture, NIH director details the importance of reaching out to others.
NIH Director Francis Collins to deliver Compton Lecture Oct. 28
Collins to present “Exceptional Opportunities in Biomedical Research.”
Advanced thin-film technique could deliver long-lasting medication
Nanoscale, biodegradable drug-delivery method could provide a year or more of steady doses.
Broad Institute launches next decade with new $100 million gift
Historic pledge from Eli and Edythe Broad to propel institute into a new decade of biomedical discovery to benefit patients.
MIT team receives $10.4 million biomanufacturing grant from DARPA
With the grant, MIT’s Biomanufacturing Research Program aims to develop new technologies that can rapidly manufacture biologic drugs on the battlefield.
Two MIT professors named Howard Hughes Medical Institute investigators
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.
The half-billion-dollar idea
While at MIT, alumnus Todd Zion developed an insulin product that ultimately drew the attention of a pharmaceutical giant.
Students have engineering on the brain
MIT class offers student teams a chance to create business ventures based on neurotechnology research.